Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Minireview

  • You have access
    Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury
    Matthew I. Hiskens
    Journal of Pharmacology and Experimental Therapeutics August 2022, 382 (2) 149-166; DOI: https://doi.org/10.1124/jpet.121.001023
  • You have access
    Therapeutic Basis of Generic Substitution of Antiseizure Medications
    Sarah Elmer and Doodipala Samba Reddy
    Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 188-196; DOI: https://doi.org/10.1124/jpet.121.000994
  • You have access
    Therapeutic Approaches to Nociplastic Pain Based on Findings in the Reserpine-Induced Fibromyalgia-Like Animal Model
    Yukinori Nagakura
    Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 106-119; DOI: https://doi.org/10.1124/jpet.121.001051
  • You have access
    Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance
    Craig K. Svensson
    Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 22-32; DOI: https://doi.org/10.1124/jpet.121.000978
  • You have access
    The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview
    Fátima Virgínia Gama Justi, Gabriella Araújo Matos, Juan de Sá Roriz Caminha, Cássia Rodrigues Roque, Edinilton Muniz Carvalho, Márcio Wilker Soares Campelo, Ludmila Belayev, Luiz Gonzaga de França Lopes and Reinaldo Barreto Oriá
    Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 47-53; DOI: https://doi.org/10.1124/jpet.121.000798
  • You have access
    Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
    Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
    Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  • You have access
    5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical Development
    William B. Parker and Jaideep V. Thottassery
    Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 211-222; DOI: https://doi.org/10.1124/jpet.121.000758
  • You have access
    The Soluble (Pro)Renin Receptor in Health and Diseases: Foe or Friend?
    Manman Qin, Chuanming Xu and Jun Yu
    Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 251-261; DOI: https://doi.org/10.1124/jpet.121.000576
  • Open Access
    Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
    Wei Zhu, Zeenat Shyr, Donald C. Lo and Wei Zheng
    Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 166-172; DOI: https://doi.org/10.1124/jpet.121.000688
  • Open Access
    Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
    Zizhen Si and Xidi Wang
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 207-217; DOI: https://doi.org/10.1124/jpet.120.000324

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics